ABCSG 38/Lorelei Trial Summary
A phase II, randomized, double-blind study of neoadjuvant letrozole + GDC-0032 vs. letrozole + placebo in postmenopausal women with ER+/ HER2- negative primary breast cancer
|Coordinating investigator:||Dubsky, Peter; Vienna|
(Click to enlarge)
Link for studyteam-members only
Further information about this trial
Access to these informations only with keyword. If required, please ask the responsible project manager.